<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>&#13;
&#13;
<head>&#13;
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet"/>&#13;
    <link href="./static/css/outliers.css" rel="stylesheet"/>&#13;
    <meta charset="UTF-8"/>&#13;
</head>&#13;
&#13;
<body>&#13;
    <div class="container"><h1>Static outliers for NHS East Sussex CCG</h1>
<p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
    explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
    prescribers and organisations to audit and review prescribing.</p>
<p>The below reports have been developed to use &#8220;z-scores&#8221; to automatically identify prescribing patterns at a chemical level which are furthest away from &#8220;typical prescribing&#8221; and can be classified as an &#8220;outlier&#8221;. It is important to remember that
    this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
    method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
    We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the &#8220;z-score&#8221;, which is a measure
    of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your &#8220;z-scores&#8221; to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
    for prescribing lower than its peers.</p>
<p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&amp;entry.2016356131=ccg+97R">survey</a>
    or emailing us at
    <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
    feedback.
</p><h2>Prescribing where NHS East Sussex CCG is higher than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0409010I0&amp;denomIds=4.9.1&amp;selectedTab=summary">Levodopa</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Dopaminergic drugs used in parkinsonism</td>&#13;
      <td>22949</td>&#13;
      <td>0.00</td>&#13;
      <td>0.0</td>&#13;
      <td>0.00</td>&#13;
      <td>10.20</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0409010I0AAAMAM&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Levodopa 25mg/5ml oral suspension : 1</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0501070Z0&amp;denomIds=5.1.7&amp;selectedTab=summary">Pristinamycin</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>5</td>&#13;
      <td>Some other antibacterials</td>&#13;
      <td>802</td>&#13;
      <td>0.01</td>&#13;
      <td>0.0</td>&#13;
      <td>0.00</td>&#13;
      <td>6.84</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0501070Z0AAAAAA&amp;denomIds=5.1.7&amp;selectedTab=summary" target="_blank">Pristinamycin 500mg tablets : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0106060A0&amp;denomIds=1.6.6&amp;selectedTab=summary">Methylnaltrexone bromide</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>5</td>&#13;
      <td>Peripheral opioid-receptor antagonists</td>&#13;
      <td>78</td>&#13;
      <td>0.06</td>&#13;
      <td>0.0</td>&#13;
      <td>0.01</td>&#13;
      <td>6.61</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0106060A0AAAAAA&amp;denomIds=1.6.6&amp;selectedTab=summary" target="_blank">Methylnaltrexone bromide 12mg/0.6ml inj vials : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0409010S0&amp;denomIds=4.9.1&amp;selectedTab=summary">Tolcapone</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>30</td>&#13;
      <td>Dopaminergic drugs used in parkinsonism</td>&#13;
      <td>22949</td>&#13;
      <td>0.00</td>&#13;
      <td>0.0</td>&#13;
      <td>0.00</td>&#13;
      <td>6.20</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0409010S0AAAAAA&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Tolcapone 100mg tablets : 30</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0401020R0&amp;denomIds=4.1.2&amp;selectedTab=summary">Meprobamate</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>4</td>&#13;
      <td>Anxiolytics</td>&#13;
      <td>35279</td>&#13;
      <td>0.00</td>&#13;
      <td>0.0</td>&#13;
      <td>0.00</td>&#13;
      <td>5.93</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAFsUlEQVR4nO3dX6gUZRzG8e8cT1pEVlBIUTkoGiFqXQiZpoLUzZSERJRGSIZEphdhNZVp9HfMLkorLVJK70owokkptVQqMekiMAmFpoIosT8WlOCfXxcz53A4aGfX3Zl3zr7PB4Y97tnd5909PmfenX33bGBmiIgfulwPQESqo8KLeESFF/GICi/iERVexCMqvIhHVHgRj6jwIh5R4UU8osKLeESFl84XBFo/Xugu40bDOP0C+AtYmiXRvjIyRKR5QRlvngnjdBQwFlgJ7AUWZkl0rO1BIo0IAsMscD2MOiil8D3COO0GXgQuB+ZkSXSqtDCRM1Hhe5X6HD5LohPAkuKfz5WZJSIDK/2gXbFXnwfcGMbpnLLzROTMSp3S9xXG6VXATmBSlkRHKgkVAU3p+6jsZbksiX4EVpM/pxcRB6p+HX4VMDGM0xkV54oIFU7pe4RxOglYB1yXJdHJSsPFT5rS96p8pV2WRF8BB4A7q84W8Z2rpbXLgGVhnA51lC/iJSeFz5LoO2A3cK+LfBFfuXzzzNPAI2GcnudwDCJecVb44mW6D4CFrsYg4hvXb499AVgUxumFjsch4gWnhc+S6FdgI/CQy3GI+ML1Hh7gJWBeGKeXuh6ISKdzXvgsif4EXgcedz0WkU7nvPCF1cBtYZyOdD0QkU5Wi8JnSfQPkABPOR6KSEerReEL64Hrwzgd53ogIp2qNoXPkug4sBxY4XosIp2qNoUvvAcMD+M0cj0QkU5U+dtjBxLG6QTgXeBa/aVbaQu9PbZX3fbwZEn0DfAxWowj0na1K3xhGXBfGKdXux6ISCepZeGLxTiLgI1hnJ7jejwinaKWhQfIkigF9pHv7UWkDWpb+MISYHYYpzNdD0SkE9S68MUKvNuBt8I4He96PCKDXa0LD5Al0QHgHmBzGKdXuB6PyGBW+8IDZEm0G4iB7WGcXuN6PCKD1aAoPECWRJuAB4CP9Jxe5OzUbqXdQIo9/CZgB7A0S6KjjockdaeVdr0GXeEBwjgdRn4Efz6wBlifJdFvbkcltaXC9xqUhe8RxumVwP3A3cBe8iW5O4Dvi4+pFlHh+xjUhe9R7PGnATcB04GRwE/Az8CRPtsfwPFiO9Hv9CQw0IPRyIPVrsv0CGrwtYvsLmBIn9P+2+nOP+152YpbHg4f/fCVPucZcKrYTg5werbf+7/LnOo3xu4z3MdGtq4siZbTKDNr+wYsKON2lalMZba2lXWUfkFJt6tMZSqzBYPmZTkRaZ0KL+KRsgr/Zkm3q0xlKrMFHXGUXkQaoym9iEe6m7lwEATTgBuAw2a2PgiC2cBo4BCwH5hL/lr3q8CzxdWeABYDFwMbgAk91zGzzRVlTgHGAVvM7NMqMs3sUBAEa4G3zWxPRffzMmAysMfMdlWUOR24AMDMXi4xcxFwrpklQRDMB0YAO83s84oyFwNjgDVm9m1FmUPJl5EvMLNfBspsRLN7+MlmlgA9H/w4xsxWAmOBiHzgw4CJwCfAtuLrocX3bu13nUoyzewdYC0wqqrM4gf8WYN5bckEZgH/ki/sqCpzCHn5DpeZ2e+XySVm9jwwtapMM1sFbCb/pVrV/ZwLbG0wryHNFr7/E/5GDwBYn8s2e9Cg5cwgCM4nX3e/oapM8pnMVPLZRVWZw81sNXBzhZldZvYY+d6rzMxWrtNyZhAEI4ApZra9qkxgPM39HxpQUwftimnKZOB34GvyJayjgYPAAeAu8mnKa8AzxdWWkk8BLyL/LPieKf1BM3u/oswnyadS28zsyyoyiyn9DOBYE1P6djy2IXDUzNZVlDmLfCns32Y24BHnFjLvAOYADwIzyWcVu5qY0rea+Qb5XniLme2vItPMfgiCYB6wtV1Teh2lF/GIjtKLeESFF/GICi/iERVexCMqvIhHVHgRj6jwIh5R4UU8osKLeESFF/GICi/ikf8AXnCP66RoagcAAAAASUVORK5CYII="/></td>&#13;
    </tr>&#13;
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0401020R0AAABAB&amp;denomIds=4.1.2&amp;selectedTab=summary" target="_blank">Meprobamate 400mg tablets : 4</a></div></td></tr></tbody></table>&#13;
&#13;
        <h2>Prescribing where NHS East Sussex CCG is lower than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0503031B0&amp;denomIds=5.3.3&amp;selectedTab=summary">Entecavir</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>0</td>&#13;
      <td>Chronic hepatitis B</td>&#13;
      <td>1</td>&#13;
      <td>0.00</td>&#13;
      <td>0.94</td>&#13;
      <td>0.19</td>&#13;
      <td>-4.91</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAGWElEQVR4nO3dXagUdRzG8e8cPWnn9I69QFBTkRdqGlaUlb1rxIT0QmVXhaYFQRcROUVFRMRQFwWZmVD0clGBUoJDFpWWvXhR9kIEocXQRYhFZFqadvx1MbM5jnuOe/btv3Pm+cCfmVk9u8+u8+zMzplxPTNDRKqhz3UAEekeFV6kQlR4kQpR4UUqRIUXqRAVXqRCVHiRClHhRSpEhRepEBVepEJaK7zn6bxckRIZ7zqAiNTnh3E/MBu4EjgVOAUYSKLg3GbvU4UX6TF+GE8F7gPmAF8Aa4F1wM/A363ct9fS1XKeZ5h5rQQQkVRW9EeBKUAErEqioKWCF2kLL+KYH8YTgIeAW4BHgPlJFAx14rFUeBGH/DA+B3gZ+BCYmUTBzk4+ngov4ogfxouAJcDtSRR80o3HVOFFuswP44nAUuA04MIkCrZ167F14o1IF/lhfBzwHvAHcHU3yw7awot0jR/GPrAGWJZEwTIXGVR4kS7ww3gasBq4N4mC1a5yqPAiHeaH8UxgJXBbEgUbXGZR4UU6yA/j84E3gFuTKNjoOo8O2ol0iB/Gs4HXgRt7oeygwot0hB/GVwGvAPOSKNjkOk+NCi/SZn4YB8By4JokCr5znSdPhRdpIz+MrweeBuYmUfCD6zxFKrxIm/hhfCvwBHBVEgU/uc5Tj47Si7SBH8YLgHuBK5Mo+MV1nuGo8CIt8sP4fuAm4PIkCn51nWckKrxIk/ww9oAngZnAFUkU7HAc6ZBUeJEm+GE8HlgBHA0ESRTsdhypITpoJzJK2eWtK4F/gZvLUnZQ4UVGJbu8dS3wPXBnp/4rqk7RLr1Ig/wwngKsApYmUfCc6zzNUOFFGpCdPbcUuCOJgg9c52mWCi8yguzLIB4DrgHmJFGwxXGklugzvMgw/DA+hfQLII4FZpW97KAtvMhBst+vLwIeBJYkUfCm40hto8KL5PhhPBl4HtgOXJBEwVbHkdpKhRfh/1+3PQxcS7plX5lEwZj7dmQVXirND+NjgLtJd+FXANOTKNjlNlXnqPBSSX4Ynw7cCcwHXgXO6/ULX9pBhZfK8MP4KCAAFgAnAy8CZyVR8KfTYF2kr4uWMSs72j4FuJT0s/k04F3gNWDDWPyMfigqfAX4YdwHDABHZOMwoJ90D6+/MD8e8IB9wFA28vNDpBeN7MqNv7PpXlcl8sN4EDgDmAycnY0ZQAJ8RFr0z8p27nu7tVx4f8ma64DanVhu7Glg/FObT6JgX/NBxoZsizSRtJSD7C/oYJ3bin9Wbwxkd70P+AvYmU33AHtJi7u3zrwB43Kjr7A8Hjg8Nway6WG5p7OH/W8EI43dheVaIfPr0rhhXoNJwEnACdnj/QhsBr4BvgK+HcsH4JrRjsK/UFvKBqQrSD/pClAbEwrLxdv7sp+3bLqX3BtCbr7RaW2l3pcbQ4XlercNZY/flxvF5eFGf+75TCjMF6eHs38FHsw9992kxayVs950pJH/O7tcbHGzN65+DnwzaHTUXm9y0+IbVm36G7AV+DWJgn87/bzGgpYK73neYjNb0cY8HVW2vFC+zGXLC+XL3EreVs+lX9ziz3db2fJC+TKXLS+UL3PTeXXxjEiFqPAiFdJq4UvzuSdTtrxQvsxlywvly9x03taO0otIqWiXXqRCRnUuved5lwAXAtvM7CXP824gPbtpi5m91YmAraqT+TZgKvCOma1zm+5gxbzZbcuBl82sJ75jvKjOazwbmAVsNLOP3aY7WJ28C4EjAczsGafhhuF53mXAXWY2P1teCJwIfGRmnzZ6P6Pdws8yswg4Pls+08yeIj2dsVcdkNnMXiH9Kt/TnaYa3gF5szfV9U4THVpxvZhHetZcr549Wcw7jrQ829xFGpmZrQe+zt00ycyeAC4ezf2MtvDFD/xlOABwQEbP8waBhaSXRPai4ms6nfQf9SIHWRpVzHyUmT0LzHURpgHFvH1m9gDp3mpZNNW9UR20y3aFZgG/A5uAU0lfpM1m9nYzATqtTuZ7gC3A+2b2ucts9RTzmtmX2e7c7h7fpS+uFz6w3cxedBitrjp5LyU9jXdHr55x53neDOBxYCPpxmoO6V7Jx6PZpddRepEK0VF6kQpR4UUqRIUXqRAVXqRCVHiRClHhRSpEhRepEBVepEJUeJEKUeFFKkSFF6mQ/wAEyTvaxxn1+gAAAABJRU5ErkJggg=="/></td>&#13;
    </tr>&#13;
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div/></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0801010H0&amp;denomIds=8.1.1&amp;selectedTab=summary">Cyclophosphamide</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>0</td>&#13;
      <td>Alkylating drugs</td>&#13;
      <td>1</td>&#13;
      <td>0.00</td>&#13;
      <td>0.95</td>&#13;
      <td>0.21</td>&#13;
      <td>-4.54</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div/></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0106060B0&amp;denomIds=1.6.6&amp;selectedTab=summary">Naloxegol</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>68</td>&#13;
      <td>Peripheral opioid-receptor antagonists</td>&#13;
      <td>78</td>&#13;
      <td>0.87</td>&#13;
      <td>0.98</td>&#13;
      <td>0.04</td>&#13;
      <td>-2.94</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0106060B0AAAAAA&amp;denomIds=1.6.6&amp;selectedTab=summary" target="_blank">Naloxegol 12.5mg tablets : 17</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0106060B0AAABAB&amp;denomIds=1.6.6&amp;selectedTab=summary" target="_blank">Naloxegol 25mg tablets : 47</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0106060B0BBABAB&amp;denomIds=1.6.6&amp;selectedTab=summary" target="_blank">Moventig 25mg tablets : 4</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0901040A0&amp;denomIds=9.1.4&amp;selectedTab=summary">Anagrelide hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>0</td>&#13;
      <td>Drugs used in platelet disorders</td>&#13;
      <td>5</td>&#13;
      <td>0.00</td>&#13;
      <td>0.85</td>&#13;
      <td>0.33</td>&#13;
      <td>-2.61</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div/></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0&amp;denomIds=3.2&amp;selectedTab=summary">Beclometasone dipropionate</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>32469</td>&#13;
      <td>Corticosteroids (respiratory)</td>&#13;
      <td>86778</td>&#13;
      <td>0.37</td>&#13;
      <td>0.56</td>&#13;
      <td>0.08</td>&#13;
      <td>-2.32</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0AABEBE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 50micrograms/dose inhaler CFC free : 335</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0AABFBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 100micrograms/dose inhaler CFC free : 950</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0AABGBG&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 50micrograms/dose breath actuated inh CFC free : 3</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0AABHBH&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 100mcg/dose breath actuated inhaler CFC free : 42</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0AABUBU&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 200micrograms/dose dry powder inhaler : 14</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0AABVBV&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 200micrograms/dose inhaler CFC free : 49</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0AABWBW&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 250micrograms/dose inhaler CFC free : 11</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0AABXBX&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 100microg/Formoterol 6microg/dose inh CFCfree : 374</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0AABYBY&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 100microg/Formoterol 6microg/dose dry pdr inh : 125</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0AABZBZ&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 200microg/Formoterol 6microg/dose inh CFC free : 159</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0AACACA&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 200microg/Formoterol 6microg/dose dry pdr inh : 77</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BJAABE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 50 inhaler : 1269</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BJABBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 100 inhaler : 2517</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BJACBG&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 50 Autohaler : 181</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BJADBH&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 100 Autohaler : 408</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BJAEBG&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 50micrograms/dose Easi-Breathe inhaler : 73</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BJAFBH&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 100micrograms/dose Easi-Breathe inhaler : 296</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BNAABU&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Easyhaler Beclometasone 200micrograms/dose dry pdr inhaler : 41</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BPAABE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 50micrograms/dose inhaler : 2393</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BPABBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 100micrograms/dose inhaler : 10615</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BPACBV&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 200micrograms/dose inhaler : 2583</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BPADBW&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 250micrograms/dose inhaler : 247</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BQAABX&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair 100micrograms/dose / 6micrograms/dose inhaler : 5961</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BQABBZ&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair 200micrograms/dose / 6micrograms/dose inhaler : 2746</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BRAABY&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair NEXThaler 100microg/dose / 6microg/dose dry pdr inh : 841</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BRABCA&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair NEXThaler 200microg/dose / 6microg/dose dry pdr inh : 331</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BSAABE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Kelhale 50micrograms/dose inhaler : 18</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BSABBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Kelhale 100micrograms/dose inhaler : 48</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BTAABE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Soprobec 50micrograms/dose inhaler : 13</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BTABBV&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Soprobec 200micrograms/dose inhaler : 13</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BTACBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Soprobec 100micrograms/dose inhaler : 79</a><br/><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=97R&amp;numIds=0302000C0BTADBW&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Soprobec 250micrograms/dose inhaler : 5</a></div></td></tr></tbody></table>&#13;
&#13;
    </div><script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"/>&#13;
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"/>&#13;
</body>&#13;
&#13;
</html>